Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.44 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.44 |
| ▸ | CHRNB3 | Q05901 | 1/20 | 0.44 |
| ▸ | CHRNA6 | Q15825 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.43 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3288960 | 1.00 | EPHX2 (0.47) | EPHX2MEN1KMT2ACHRNB2CHRNA3 | |
| SCHEMBL12182476 | 0.89 | MEN1 (0.58) | EPHX2MEN1KMT2ALMNAPOLB | |
| SCHEMBL4259604 | 0.88 | L3MBTL1 (0.54) | EPHX2L3MBTL1LMNAPOLBALDH1A1 | |
| SCHEMBL3287083 | 0.84 | CHRNB2 (0.55) | EPHX2MEN1KMT2ACHRNB2CHRNA3 | |
| SCHEMBL14978998 | 0.83 | GAA (0.54) | EPHX2MEN1KMT2ACHRNB2CHRNA3 | |
| SCHEMBL8271230 | 0.82 | L3MBTL1 (0.45) | L3MBTL1LMNAPOLBSMN1; SMN2 | |
| SCHEMBL1360162 | 0.82 | L3MBTL1 (0.45) | L3MBTL1LMNAPOLBSMN1; SMN2 | |
| SCHEMBL1336912 | 0.81 | ALDH1A1 (0.53) | L3MBTL1LMNAPOLBALDH1A1 | |
| SCHEMBL8271235 | 0.80 | POLB (0.44) | MEN1KMT2AL3MBTL1LMNAPOLB | |
| SCHEMBL11936428 | 0.80 | SMN1; SMN2 (0.54) | EPHX2MEN1KMT2AL3MBTL1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110251379-A1 | COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS | SATORI PHARMACEUTICALS, INC. (US) | 2011-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110251379-A1 | COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS | CLN6, NLN, ACHE | EPHX2 1265/4885MEN1 2203/4885KMT2A 2061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.